首页> 外文OA文献 >A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel spiroindolone KAE609, to assess the safety, tolerability and pharmacokinetics in healthy adult volunteers

【2h】

A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel spiroindolone KAE609, to assess the safety, tolerability and pharmacokinetics in healthy adult volunteers

机译：新型螺螺吲哚酮KAE609的首次人类随机，双盲，安慰剂对照，单次和多次递增口服剂量研究，以评估健康成人志愿者的安全性，耐受性和药代动力学

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel spiroindolone KAE609, to assess the safety, tolerability and pharmacokinetics in healthy adult volunteers [J] . Joel Leong, Ruobing Li, Jay Prakash Jain, Malaria Journal . 2014,第S1期

机译：新型螺螺吲哚酮KAE609的首次人类随机，双盲，安慰剂对照，单次和多次递增口服剂量研究，以评估健康成人志愿者的安全性，耐受性和药代动力学
2. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers [J] . LeongF.J., ZhaoR., ZengS., Antimicrobial agents and chemotherapy. . 2014,第11期

机译：新型咪唑并哌嗪KAF156的首次人类随机，双盲，安慰剂对照，单次和多次递增口服剂量研究，以评估其在健康成人志愿者中的安全性，耐受性和药代动力学
3. A first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study to assess the safety and tolerability of LFF571 in healthy volunteers [J] . TingL.S.L., PraestgaardJ., GrunenbergN., Antimicrobial agents and chemotherapy. . 2012,第11期

机译：一项人类首次，随机，双盲，安慰剂对照，单次和多次递增口服剂量研究，旨在评估LFF571在健康志愿者中的安全性和耐受性
4. A Phase I, Double-Blind, Randomized, Dose Escalating Crossover Study ofan Oral Formulation of Human Growth Hormone in Healthy Male Volunteers [C] . Steven M. Dinh, Puchun Liu, Ehud Arbit, Controlled Release Society annual meeting . 2004

机译：健康男性志愿者中人类生长激素口服制剂的I期，双盲，随机，剂量递增交叉研究
5. A first-in-human randomized double-blind placebo-controlled single- and multiple-ascending oral dose study of novel spiroindolone KAE609 to assess the safety tolerability and pharmacokinetics in healthy adult volunteers [O] . Joel Leong, Ruobing Li, Jay Prakash Jain, 2014

机译：新型螺螺吲哚酮KAE609的首次人类随机双盲安慰剂对照单次和多次递增口服剂量研究以评估健康成人志愿者的安全性耐受性和药代动力学
6. A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers [O] . F. Joel Leong, Rong Zhao, Shuqi Zeng, 2014

机译：新型咪唑哌嗪KAF156的第一单人随机，双盲，安慰剂，单位和多升口服剂量研究，以评估健康成人志愿者的安全性，耐受性和药代动力学
7. Double-Blind Placebo-Controlled Rising Dose Toxicity and Acceptability Study of Wr-5677 in Healthy Adult Male Volunteers [R] . Colmore, J. P., Desper, P. C., Kyriakopoulos, A. A., 1969

机译：Wr-5677在健康成年男性志愿者中的双盲安慰剂对照上升剂量毒性和可接受性研究

A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel spiroindolone KAE609, to assess the safety, tolerability and pharmacokinetics in healthy adult volunteers

著录项

引文网络

相似文献

相关主题

期刊订阅